Tony Michael Argenbright

Array ( [id] => 5710938 [patent_doc_number] => 20060052283 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-09 [patent_title] => 'The Sperm Binding Ligand HIPRTY and Its Involvement in Embryo Cleavage' [patent_app_type] => utility [patent_app_number] => 10/711268 [patent_app_country] => US [patent_app_date] => 2004-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3747 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20060052283.pdf [firstpage_image] =>[orig_patent_app_number] => 10711268 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7127862 [patent_doc_number] => 20050059606 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-17 [patent_title] => 'Novel peptides as NS3-serine protease inhibitors of hepatitis C virus' [patent_app_type] => utility [patent_app_number] => 10/934141 [patent_app_country] => US [patent_app_date] => 2004-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24987 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20050059606.pdf [firstpage_image] =>[orig_patent_app_number] => 10934141 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7230759 [patent_doc_number] => 20050079178 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-14 [patent_title] => 'Inhibitor of cardiac tachyarrhythmias' [patent_app_type] => utility [patent_app_number] => 10/927616 [patent_app_country] => US [patent_app_date] => 2004-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 20846 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0079/20050079178.pdf [firstpage_image] =>[orig_patent_app_number] => 10927616 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7026425 [patent_doc_number] => 20050020488 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-27 [patent_title] => 'Process for preparing glycopeptide phosphonate derivatives' [patent_app_type] => utility [patent_app_number] => 10/926148 [patent_app_country] => US [patent_app_date] => 2004-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6075 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20050020488.pdf [firstpage_image] =>[orig_patent_app_number] => 10926148 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 935446 [patent_doc_number] => 06974795 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-12-13 [patent_title] => 'Compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin' [patent_app_type] => utility [patent_app_number] => 10/925067 [patent_app_country] => US [patent_app_date] => 2004-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 12526 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/974/06974795.pdf [firstpage_image] =>[orig_patent_app_number] => 10925067 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7237587 [patent_doc_number] => 20050080012 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-14 [patent_title] => 'Sustained release pharmaceutical compounds to prevent abuse of controlled substances' [patent_app_type] => utility [patent_app_number] => 10/923257 [patent_app_country] => US [patent_app_date] => 2004-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 13122 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0080/20050080012.pdf [firstpage_image] =>[orig_patent_app_number] => 10923257 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 707862 [patent_doc_number] => 07060679 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-06-13 [patent_title] => 'Conformationally constrained backbone cyclized somatostatin analogs' [patent_app_type] => utility [patent_app_number] => 10/916522 [patent_app_country] => US [patent_app_date] => 2004-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 16695 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 134 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/060/07060679.pdf [firstpage_image] =>[orig_patent_app_number] => 10916522 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5643221 [patent_doc_number] => 20060281676 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-14 [patent_title] => 'Agent and method for the treatment and prevention of tse and method for the production of said agent' [patent_app_type] => utility [patent_app_number] => 10/570233 [patent_app_country] => US [patent_app_date] => 2004-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4127 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20060281676.pdf [firstpage_image] =>[orig_patent_app_number] => 10570233 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7089628 [patent_doc_number] => 20050009741 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-13 [patent_title] => 'Ionic molecular conjugates of N-acylated derivatives of poly(2-amino-2-deoxy-D-glucose) and polypeptides' [patent_app_type] => utility [patent_app_number] => 10/900220 [patent_app_country] => US [patent_app_date] => 2004-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9855 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20050009741.pdf [firstpage_image] =>[orig_patent_app_number] => 10900220 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7218158 [patent_doc_number] => 20050054838 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-10 [patent_title] => 'Method of isolating and purifying aequorin, aequorin produced by the method, and process for detecting calcium ions with aequorin' [patent_app_type] => utility [patent_app_number] => 10/895900 [patent_app_country] => US [patent_app_date] => 2004-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4640 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20050054838.pdf [firstpage_image] =>[orig_patent_app_number] => 10895900 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5704725 [patent_doc_number] => 20060193773 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-31 [patent_title] => 'Imaging agents' [patent_app_type] => utility [patent_app_number] => 10/566487 [patent_app_country] => US [patent_app_date] => 2004-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6349 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0193/20060193773.pdf [firstpage_image] =>[orig_patent_app_number] => 10566487 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4445350 [patent_doc_number] => 07863413 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-01-04 [patent_title] => 'Peptide protein translation inhibitor and the use thereof for protein translation control' [patent_app_type] => utility [patent_app_number] => 10/565438 [patent_app_country] => US [patent_app_date] => 2004-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 11 [patent_no_of_words] => 11385 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/863/07863413.pdf [firstpage_image] =>[orig_patent_app_number] => 10565438 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5142417 [patent_doc_number] => 20070004633 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-04 [patent_title] => 'Use of peptidic conjugates for preparing compositions for alopecia preventive and curative treatment' [patent_app_type] => utility [patent_app_number] => 10/565007 [patent_app_country] => US [patent_app_date] => 2004-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2198 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20070004633.pdf [firstpage_image] =>[orig_patent_app_number] => 10565007 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5631553 [patent_doc_number] => 20060148023 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-06 [patent_title] => 'Affinity labeling of serine proteases for simultaneous detection of multiple serine protease activity levels' [patent_app_type] => utility [patent_app_number] => 10/872824 [patent_app_country] => US [patent_app_date] => 2004-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6076 [patent_no_of_claims] => 60 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20060148023.pdf [firstpage_image] =>[orig_patent_app_number] => 10872824 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5183694 [patent_doc_number] => 20070055048 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-08 [patent_title] => 'Process for supported phase synthesis' [patent_app_type] => utility [patent_app_number] => 10/562998 [patent_app_country] => US [patent_app_date] => 2004-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5459 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20070055048.pdf [firstpage_image] =>[orig_patent_app_number] => 10562998 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5057575 [patent_doc_number] => 20070060497 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-15 [patent_title] => 'Reagents for modifying biopharmaceuticals, the use and production thereof' [patent_app_type] => utility [patent_app_number] => 10/559996 [patent_app_country] => US [patent_app_date] => 2004-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10813 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0060/20070060497.pdf [firstpage_image] =>[orig_patent_app_number] => 10559996 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 478753 [patent_doc_number] => 07223735 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-05-29 [patent_title] => 'Abuse resistant lysine amphetamine compounds' [patent_app_type] => utility [patent_app_number] => 10/857619 [patent_app_country] => US [patent_app_date] => 2004-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 55 [patent_figures_cnt] => 71 [patent_no_of_words] => 26232 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/223/07223735.pdf [firstpage_image] =>[orig_patent_app_number] => 10857619 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 658295 [patent_doc_number] => 07105486 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-09-12 [patent_title] => 'Abuse-resistant amphetamine compounds' [patent_app_type] => utility [patent_app_number] => 10/858526 [patent_app_country] => US [patent_app_date] => 2004-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 55 [patent_figures_cnt] => 71 [patent_no_of_words] => 26288 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/105/07105486.pdf [firstpage_image] =>[orig_patent_app_number] => 10858526 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4624300 [patent_doc_number] => 08003596 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-23 [patent_title] => 'P-selectin targeting ligand and compositions thereof' [patent_app_type] => utility [patent_app_number] => 10/558492 [patent_app_country] => US [patent_app_date] => 2004-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8243 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/003/08003596.pdf [firstpage_image] =>[orig_patent_app_number] => 10558492 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 281812 [patent_doc_number] => 07553812 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-06-30 [patent_title] => 'Acyclovir-peptide analogs' [patent_app_type] => utility [patent_app_number] => 10/854533 [patent_app_country] => US [patent_app_date] => 2004-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 28 [patent_no_of_words] => 21930 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/553/07553812.pdf [firstpage_image] =>[orig_patent_app_number] => 10854533 [rel_patent_id] =>[rel_patent_doc_number] =>)